Wall Street Breakfast Podcast: Carvana Drops Despite Higher Sales
Source: SeekingAlpha
2026-02-19 06:51:53 ET
Listen below or on the go via Apple Podcasts and Spotify
Carvana's (CVNA)Q4 profitability loses traction; shares crater more than 20%. (00:14) DoorDash ( DASH ) sees double-digit growth in orders, GOV; sets upbeat Q1 guidance. (01:31) Moderna ( MRNA ) gains as FDA backtracks and accepts flu shot for review. (02:14)...
Read the full article on Seeking Alpha
For further details see:
Wall Street Breakfast Podcast: Carvana Drops Despite Higher Sales
Moderna Inc.
NASDAQ: MRNA
MRNA Trading
-5.62% G/L:
$53.87 Last:
2,194,845 Volume:
$54.75 Open:
MRNA Latest News
MRNA Stock Data
$16,877,354,918
348,095,445
0.39%
298
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
